Roxanne C. Jewell

A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30‐Minute Intravenous Infusion in Patients With Cancer

M. Borad, D. Northfelt, P. Lebowitz, 2010, Journal of clinical pharmacology.

Ofatumumab, the first human anti‐CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

R. Jewell, I. Gupta, Roxanne C. Jewell, 2012, Annals of the New York Academy of Sciences.

Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis

A. Hagenbeek, B. Coiffier, M. Østergaard, 2014, Journal of clinical pharmacology.

Assessment of the effect of ofatumumab on cardiac repolarization

C. Hottenstein, G. Chan, Eric Lewis, 2015, Journal of clinical pharmacology.